Healthcare  Name:  Sector:  Chief Executive: Dyax Healthcare Henry E. Blair  Summary: Developed and patented phage display technology with broad applications in the discovery and development of new therapeutic, separations, diagnostic and industrial enzyme products.  Stage of Initial  Investment: Seed/Early  Liquidity: Nasdaq: DYAX 300 Technology Square Cambridge, MA 02139 Phone: 617.225.2500 Fax: 617.225.2501
	Copyright ©2009 Rho Capital Partners, Inc.